Table 4 Follow-up outcomes and fibroid recurrence.
Outcome | Control group (N = 55) | 3D model group (N = 55) | P value |
|---|---|---|---|
Immediate post-operative (24–48 h) | |||
Residual fibroid tissue—no. (%) | 4 (7.3) | 1 (1.8) | 0.363 |
Mean residual fibroid size—mm | 7.7 ± 0.9 | 5.3 (single case) | 0.156 |
Six-month follow-up | |||
New small fibroids (< 2 cm)—no. (%) | 2 (3.6) | 0 (0.0) | 0.495 |
One-year follow-up | |||
Overall fibroid recurrence—no. (%) | 7 (12.7) | 1 (1.8) | 0.060 |
New fibroid development—no. (%) | 4 (7.3) | 1 (1.8) | 0.363 |
Residual fibroid growth—no. (%) | 3 (5.5) | 0 (0.0) | 0.243 |
Mean time to recurrence—months | 8.7 ± 1.3 | 11.5 (single case) | 0.287 |
Symptom resolution | |||
Heavy menstrual bleeding resolved—no. (%) | 41 (93.1)† | 42 (97.7)‡ | 0.361 |
